| 000 | 01681 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250518012450.0 | ||
| 264 | 0 | _c20200526 | |
| 008 | 202005s 0 0 eng d | ||
| 022 | _a1460-2091 | ||
| 024 | 7 |
_a10.1093/jac/dky473 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAbad, Lélia | |
| 245 | 0 | 0 |
_aEvaluation of the ability of linezolid and tedizolid to eradicate intraosteoblastic and biofilm-embedded Staphylococcus aureus in the bone and joint infection setting. _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _c03 2019 |
||
| 300 |
_a625-632 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
| 650 | 0 | 4 |
_aBiofilms _xdrug effects |
| 650 | 0 | 4 |
_aGranulocyte Precursor Cells _xmicrobiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLinezolid _xpharmacology |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 | _aModels, Theoretical |
| 650 | 0 | 4 |
_aOsteoarthritis _xmicrobiology |
| 650 | 0 | 4 |
_aOxazolidinones _xpharmacology |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xmicrobiology |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
| 650 | 0 | 4 |
_aTetrazoles _xpharmacology |
| 700 | 1 | _aTafani, Virginie | |
| 700 | 1 | _aTasse, Jason | |
| 700 | 1 | _aJosse, Jérôme | |
| 700 | 1 | _aChidiac, Christian | |
| 700 | 1 | _aLustig, Sébastien | |
| 700 | 1 | _aFerry, Tristan | |
| 700 | 1 | _aDiot, Alan | |
| 700 | 1 | _aLaurent, Frédéric | |
| 700 | 1 | _aValour, Florent | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 74 _gno. 3 _gp. 625-632 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/dky473 _zAvailable from publisher's website |
| 999 |
_c29131256 _d29131256 |
||